Gemita 200mg Injection (Gemcitabine 200mg)

Gemita 200mg Injection

Gemita 200 MG Injection is an anticancer agent which is used in the treatment of cancer of pancreas, breast, lungs and ovaries. It should be used under the supervision of a qualified physician. Close monitoring of lung function and blood cell count are necessary while receiving this medication.

Substitutes

List of substitutes for Gemita 200 MG Injection
Cytogem 200 MG Injection
Dr. Reddys Laboratories Ltd.
Gemitrate 200 MG Injection
Torrent Pharmaceuticals Ltd.
Gemizan 200 MG Injection
Zuventus Healthcare Ltd.
Tabicad 200 MG Injection
Cadila Pharmaceuticals Ltd.
Xtroz 200 MG Injection
Ranbaxy Laboratories Ltd.

Side effects

Major & minor side effects for Gemita 200 MG Injection
Low WBC and Platelet count
Pale skin
Fever
Nausea and Vomiting
Diarrhea
Weakness of arms, hands, legs or feet
Headache
Hair loss or thinning of the hair
Drowsiness
Skin rash
Swelling and redness at the injection site

Uses of Gemita 200 MG Injection

What is it prescribed for?
Pancreatic Cancer
Gemita 200 MG Injection is used along with other medications in the treatment of pancreatic cancer.
Non-Small Cell Lung Cancer
Gemita 200 MG Injection is used along with other medications in the treatment of lung cancer.
Breast cancer
Gemita 200 MG Injection is used along with other medications in the treatment of breast cancer.
Ovarian Cancer
Gemita 200 MG Injection is used along with other medications in the treatment of ovarian cancer.

Related Products

List of related products
Gemita 1000 MG Injection
Gemita 1400 MG Injection

When not to use?

Allergy
Not recommended in patients with known allergy to Gemita 200 MG Injection

Warnings

Warnings for special population
Pregnancy
This medicine is not recommended for pregnant women.
Breast-feeding
This medicine is not recommended in breastfeeding women.
General warnings
Liver injury
This medicine may cause liver injury and causes death. The liver function parameters need to be assessed before starting the treatment. The treatment should be discontinued if any signs and symptoms of liver injury appear.
Kidney injury
This medicine may cause Hemolytic Uremic Syndrome (HUS) which is a serious condition that causes fatalities. The kidney function parameters need to be assessed before starting the treatment. The treatment should be discontinued if any signs and symptoms of kidney injury appear.
Lung toxicity
This medicine may cause severe lung injuries like pulmonary fibrosis, pulmonary interstitial infiltrates. Any symptoms of breathing difficulty and signs of lung impairment should be informed to the doctor. The treatment should be discontinued if any symptoms appear.
Decrease in blood cell count
This medicine may lower the white blood cell count (neutrophils) and platelets. Close monitoring of blood cell count is necessary. The baseline of the blood cell count should be obtained before initiation of the treatment. Do not start the treatment if the counts are less.
Infections
The chances of occurring infections are more in patients receiving this medicine. Hold the chemotherapy and start with the broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary.

Dosage

Missed Dose
It is advised not to miss any dose. If you missed any dose, you should contact your doctor immediately.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

General Instructions

This medicine is given in multiple cycles. It is important to receive the every scheduled dose and make a note of next scheduled dose. Close monitoring of blood cells counts and lung function is necessary.